Fulcrum Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Fulcrum Therapeutics

31/07/2024 14:53

* Fulcrum Therapeutics Inc  FULC.OQ  reported quarterly
adjusted
earnings of 87 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -38 cents.  The mean expectation of
nine analysts for the quarter was for a loss of one cent per
share. Wall Street expected results to range from -46 cents
to 74 cents per share.
    * Revenue rose 8,990.9% to $80.00 million from a year ago;
analysts expected $36.55 million. 
    * Fulcrum Therapeutics Inc's reported EPS for the quarter
was 87
cents​.
    * The company reported quarterly net income of $55.41
million.
    * Fulcrum Therapeutics Inc shares had risen by 35.6% this
quarter and gained 24.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 97.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Fulcrum
Therapeutics Inc is $16.00 
This summary was machine generated from LSEG data July 31 at
01:53 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.01          0.87           Beat
 Mar. 31 2024                     -0.43          
 Dec. 31 2023      -0.43          -0.40          Beat
 Sep. 30 2023      -0.43          -0.39          Beat